Literature DB >> 17258783

Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans.

Lily Tsai1, Nataliya Trunova, Agegnehu Gettie, Hiroshi Mohri, Rudolf Bohm, Mohammed Saifuddin, Cecilia Cheng-Mayer.   

Abstract

We examined the effect of inoculum dose on SHIV transmission and infection. We found that repeated low-dose intravaginal exposure with either R5-SHIV(SF162P3) or X4-SHIV(SF33A) results in infections that are blunted and rapidly controlled. Interestingly, although the transmission rate after all repeated exposures is comparable for the two viruses, the probability of low-dose vaginal transmission is greater for the X4 than R5 virus. Furthermore, X4-SHIV(SF33A) replication predominates in low-dose dually-exposed macaques, suggesting that it is better at establishing a systemic infection following transmission. However, X4-SHIV(SF33A) advantage in transmission and infection is not observed in macaques inoculated intravenously with low-dose mixed inoculum. The finding that although matched in tissue culture infectious dose, the X4 inoculum is more complex leads us to hypothesize that the greater genetic heterogeneity of the X4 virus population may have rendered it less susceptible to the severe bottleneck effects imposed by IVAG inoculation with small doses, allowing for greater probability of transmission and establishment of a generalized infection. These data have implications for HIV-1 transmission and infection in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17258783      PMCID: PMC1941575          DOI: 10.1016/j.virol.2006.12.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.

Authors:  R H Gray; M J Wawer; R Brookmeyer; N K Sewankambo; D Serwadda; F Wabwire-Mangen; T Lutalo; X Li; T vanCott; T C Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  Association of chemokine-mediated block to HIV entry with coreceptor internalization.

Authors:  Stephanie M Brandt; Roberto Mariani; Anne U Holland; Thomas J Hope; Nathaniel R Landau
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

3.  Early HIV infection in vivo: branching-process model for studying timing of immune responses and drug therapy.

Authors:  D Wick; S G Self
Journal:  Math Biosci       Date:  2000-06       Impact factor: 2.144

4.  Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.

Authors:  P A Luciw; C P Mandell; S Himathongkham; J Li; T A Low; K A Schmidt; K E Shaw; C Cheng-Mayer
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

5.  Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).

Authors:  J M Harouse; A Gettie; T Eshetu; R C Tan; R Bohm; J Blanchard; G Baskin; C Cheng-Mayer
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.

Authors:  J L Greenier; C J Miller; D Lu; P J Dailey; F X Lü; K J Kunstman; S M Wolinsky; M L Marthas
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 7.  Anti-HIV and -SIV immunity in the vagina.

Authors:  Christopher J Miller; Fabien X Lü
Journal:  Int Rev Immunol       Date:  2003 Jan-Feb       Impact factor: 5.311

8.  Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda.

Authors:  Ronald H Gray; Xianbin Li; Maria J Wawer; Stephen J Gange; David Serwadda; Nelson K Sewankambo; Richard Moore; Fred Wabwire-Mangen; Tom Lutalo; Thomas C Quinn
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

9.  CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques.

Authors:  Janet M Harouse; Clarisa Buckner; Agegnehu Gettie; Ross Fuller; Rudolf Bohm; James Blanchard; Cecilia Cheng-Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

10.  Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts.

Authors:  A J Frater; C T T Edwards; N McCarthy; J Fox; H Brown; A Milicic; N Mackie; T Pillay; J W Drijfhout; S Dustan; J R Clarke; E C Holmes; H T Zhang; K Pfafferott; P J Goulder; M O McClure; J Weber; R E Phillips; S Fidler
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

View more
  8 in total

1.  Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N.

Authors:  Madina Shakirzyanova; Lily Tsai; Wuze Ren; Agegneu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

2.  Molecular evolution analysis of the human immunodeficiency virus type 1 envelope in simian/human immunodeficiency virus-infected macaques: implications for challenge dose selection.

Authors:  Mariana Varela; Lisa Landskron; Rachel P J Lai; Trevelyan J McKinley; Willy M Bogers; Ernst J Verschoor; Rob Dubbes; Susan W Barnett; Simon D W Frost; Jonathan L Heeney
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

3.  Association of MHC-I genotypes with disease progression in HIV/SIV infections.

Authors:  Takushi Nomura; Tetsuro Matano
Journal:  Front Microbiol       Date:  2012-06-29       Impact factor: 5.640

4.  SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.

Authors:  Athe M N Tsibris; Urboshi Pal; Allison L Schure; Ronald S Veazey; Kevin J Kunstman; Timothy J Henrich; P J Klasse; Steven M Wolinsky; Daniel R Kuritzkes; John P Moore
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

5.  RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.

Authors:  Yonghou Jiang; Baoping Tian; Mohammed Saifuddin; Michael B Agy; Peter Emau; J Scott Cairns; Che-Chung Tsai
Journal:  AIDS Res Ther       Date:  2009-11-05       Impact factor: 2.250

6.  SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.

Authors:  Michael Humbert; Robert A Rasmussen; Ruijiang Song; Helena Ong; Prachi Sharma; Agnès L Chenine; Victor G Kramer; Nagadenahalli B Siddappa; Weidong Xu; James G Else; Francis J Novembre; Elizabeth Strobert; Shawn P O'Neil; Ruth M Ruprecht
Journal:  Retrovirology       Date:  2008-10-17       Impact factor: 4.602

7.  Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus.

Authors:  On Ho; Kay Larsen; Patricia Polacino; Yun Li; David Anderson; Ruijiang Song; Ruth M Ruprecht; Shiu-Lok Hu
Journal:  Retrovirology       Date:  2009-07-14       Impact factor: 4.602

8.  In vitro neutralization of low dose inocula at physiological concentrations of a monoclonal antibody which protects macaques against SHIV challenge.

Authors:  David Davis; Wim Koornstra; Zahra Fagrouch; Ernst J Verschoor; Jonathan L Heeney; Willy M J M Bogers
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.